Related Experiment Video
Updated: Jun 19, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
Treating oral histoplasmosis in an immunocompetent patient
José Luis Muñante-Cárdenas1, Adriano Freitas de Assis, Sergio Olate
1Division of Oral and Maxillofacial Surgery, Piracicaba Dental School, State University of Campinas, São Paulo, Brazil.
Background:
Histoplasmosis is a deep fungus infection that occurs worldwide and is caused by Histoplasma capsulatum. Oral histoplasmosis has been of considerable importance in recent years because it occurs frequently in immunosuppressed patients, more often in those who test positive for the human immunodeficiency virus (HIV). However, the literature contains reports of histoplasmosis in immunocompetent patients, especially in endemic areas.
Case Description:
The authors describe a case of an HIV-negative, immunocompetent 60-year-old man with ulcerative and painful oral lesions. The clinician included squamous cell carcinoma and systemic mycosis in the differential diagnosis. After the patient underwent a biopsy and a definitive diagnosis was reached, his initial treatment regimen included itraconazole (200 milligrams per day for one month), nystatin and chlorhexidine mouthrinse (0.12 percent, 10 milliliters, two times a day). The itraconazole treatment was continued for three more months (100 mg daily) until the lesions had resolved completely.
Clinical Implications:
Clinicians need to conduct a careful clinical evaluation and make an accurate diagnosis of ulcerated oral lesions. Knowledge of the oral manifestations of histoplasmosis may enable clinicians to reach a diagnosis earlier and initiate therapy more quickly.
Insights
Oral histoplasmosis, a fungal infection, can affect immunocompetent individuals. Early diagnosis and treatment of oral lesions are crucial for effective management.
Area of Science:
- Mycology
- Infectious Diseases
Background:
- Histoplasmosis is a global deep fungal infection caused by Histoplasma capsulatum.
- Oral histoplasmosis is increasingly recognized, particularly in human immunodeficiency virus (HIV)-positive immunosuppressed patients.
- Reports also document histoplasmosis in immunocompetent individuals, especially in endemic regions.
Observation:
- A case study details an HIV-negative, immunocompetent 60-year-old male presenting with painful oral ulcers.
- Differential diagnoses included squamous cell carcinoma and systemic mycosis.
- Biopsy confirmed histoplasmosis, leading to treatment.
Findings:
- The patient received a treatment regimen including itraconazole, nystatin, and chlorhexidine mouthwash.
- A four-month course of itraconazole (initially 200 mg/day, then 100 mg/day) resulted in complete resolution of oral lesions.
Implications:
- Accurate diagnosis of oral ulcerated lesions requires careful clinical evaluation.
- Awareness of oral histoplasmosis manifestations aids earlier diagnosis and prompt treatment initiation.
Related Concept Videos
Cryptococcal Meningitis
Herpes
Toxoplasmosis
Candidiasis
Trichomoniasis
Cytomegalovirus Disease

